Antares Pharma

We at Antares Pharma leverage our pharmaceutical and medical device expertise to develop innovative products that address needs in underserved therapeutic areas.

Our relentless pursuit of better therapies that positively affect patient lives inspires our employees to serve our customers and stakeholders every day.

SEC
Filings

Form Type:
Filing Year:
Date Form Title View
2021-11-048-K8-K - Current reportSEC Link
2021-11-0410-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2021-11-028-K8-K - Current reportSEC Link
2021-10-288-K8-K - Current reportSEC Link
2021-10-188-K8-K - Current reportSEC Link
2021-08-188-K8-K - Current reportSEC Link
2021-08-0510-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2021-08-058-K8-K - Current reportSEC Link
2021-06-24S-8S-8 - Securities to be offered to employees in emSEC Link
2021-06-158-K8-K - Current reportSEC Link
2021-06-018-K8-K - Current reportSEC Link
2021-05-068-K8-K - Current reportSEC Link
2021-05-0610-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2021-04-27DEFA14ADEFA14A - Additional definitive proxy soliciting SEC Link
2021-04-27DEF 14ADEF 14A - Other definitive proxy statementsSEC Link
2021-03-058-K8-K - Current reportSEC Link
2021-03-0210-K10-K - Annual report [Section 13 and 15(d), not SSEC Link
2021-03-028-K8-K - Current reportSEC Link
2021-01-28SC 13G/ASC 13G/A [Amend] - Statement of acquisition of beSEC Link
2021-01-118-K8-K - Current reportSEC Link
2020-11-128-K8-K - Current reportSEC Link
2020-11-0510-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2020-11-058-K8-K - Current reportSEC Link
2020-10-018-K8-K - Current reportSEC Link
2020-09-218-K8-K - Current reportSEC Link
2020-08-068-K8-K - Current reportSEC Link
2020-08-0610-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2020-06-168-K8-K - Current reportSEC Link
2020-05-058-K8-K - Current reportSEC Link
2020-05-0510-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2020-04-27DEF 14ADEF 14A - Other definitive proxy statementsSEC Link
2020-04-27DEFA14ADEFA14A - Additional definitive proxy soliciting SEC Link
2020-04-098-K8-K - Current reportSEC Link
2020-03-048-K8-K - Current reportSEC Link
2020-03-038-K8-K - Current reportSEC Link
2020-03-0310-K10-K - Annual report [Section 13 and 15(d), not SSEC Link
2020-02-14SC 13G/ASC 13G/A [Amend] - Statement of acquisition of beSEC Link
2020-02-11SC 13G/ASC 13G/A [Amend] - Statement of acquisition of beSEC Link
2020-02-05SC 13G/ASC 13G/A [Amend] - Statement of acquisition of beSEC Link
2020-01-278-K8-K - Current reportSEC Link
2020-01-138-K8-K - Current reportSEC Link
2019-11-0510-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2019-11-058-K8-K - Current reportSEC Link
2019-09-108-K8-K - Current reportSEC Link
2019-08-0610-Q10-Q - Quarterly report [Sections 13 or 15(d)]SEC Link
2019-08-068-K8-K - Current reportSEC Link
2019-07-23S-8S-8 - Securities to be offered to employees in emSEC Link
2019-07-058-K8-K - Current reportSEC Link
2019-06-278-K8-K - Current reportSEC Link
2019-06-188-K8-K - Current reportSEC Link
Showing 1 to 50 of 550